Related Experiment Video
Updated: Jun 19, 2026
17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
A modular one-generation reproduction study as a flexible testing system for regulatory safety assessment
Richard Vogel1, Troy Seidle, Horst Spielmann
1Leubnitzer Weg 3c, 13593 Berlin, Germany. drrvogel@aol.com
Reproductive Toxicology (Elmsford, N.Y.)
|October 8, 2009
Summary
The European Union's REACH legislation requires costly reproductive toxicity tests for high production volume chemicals. An enhanced one-generation study offers a more efficient alternative to current two-generation testing, meeting regulatory needs.
Area of Science:
- Toxicology
- Chemical Safety Assessment
- Regulatory Science
Background:
- The European Union's REACH regulation mandates extensive chemical testing, including reproductive toxicity studies for high production volume (HPV) chemicals.
- Current REACH requirements for HPV chemicals involve multiple, costly studies like the two-generation reproduction toxicity study (OECD TG 416).
- These studies present significant economic and animal welfare challenges.
Purpose of the Study:
- To propose and evaluate an "enhanced" one-generation study as a more efficient alternative to the traditional two-generation study for REACH chemical safety assessments.
- To adapt the HESI-ACSA proposal for industrial chemicals under REACH, focusing on streamlined testing for reproductive and developmental toxicity.
- To present a flexible testing strategy that can be modified to meet diverse regulatory requirements.
Main Methods:
- Review and adaptation of the HESI-ACSA proposed "enhanced" one-generation study design.
- Focus on incorporating developmental toxicity endpoints within a flexible one-generation framework.
- Consideration of regulatory information requirements for high production volume chemicals under REACH.
Main Results:
- The proposed enhanced one-generation study can effectively replace routine two-generation studies for many chemicals.
- This streamlined approach addresses reproductive and developmental toxicity information needs more efficiently.
- The flexible design allows for triggered modules to investigate specific toxicological endpoints as needed.
Conclusions:
- An enhanced one-generation study offers a cost-effective and animal-welfare-conscious alternative for REACH reproductive toxicity testing.
- This adaptable testing strategy can streamline safety assessments for industrial chemicals.
- The proposed method provides a flexible system to meet evolving regulatory demands across various sectors.
Related Concept Videos
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:28Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...